Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and Relatives
Authors:
- David ZhangDZDavid Zhang
- Chad A. NewtonCNChad A. Newton
- Michael H. ChoMCMichael H. Cho
- Columbia Genomics ConsortiumCCColumbia Genomics Consortium
Preprint
Abstract
: Rationale: Idiopathic pulmonary fibrosis (IPF) is an age-related disorder with common and rare genetic risk factors. It is unknown if the effects of PF genetic risk factors differ by chronologic age. Objectives: To assess age-specific effects of genetic risk factors in PF patients and their relatives. Methods: We identified common and rare genetic risk factors using a Columbia whole genome sequencing (WGS) cohort (777 IPF, 2905 controls) and replicated findings using Trans-Omics for Precision Medicine (TOPMed, 1148 IPF, 5202 controls). We assessed age-stratified genetic risk of IPF and assessed for interaction with age across a range of cutoffs. We analyzed 313 FPF pedigrees and compared age-specific prevalence of interstitial lung disease in relatives stratified by proband genetic risk factors. Measurements and Main Results: Adjusted odds of disease from MUC5B SNP increase with age, while odds of disease from rare variants decrease with age. The magnitude of the interaction term between age and both genetic variables was greatest in younger individuals. There were significant interactions between age MUC5B SNP (discovery p interaction =0.01; replication p interaction interaction interaction =0.03). Pedigree analysis showed more prevalent disease especially in younger relatives in FPF families with rare variants versus without (pMUC5B SNP confers greater risk in older individuals. Relatives of FPF patients with rare variants exhibit earlier prevalent disease, which has implications for preclinical disease screening.Keywords
This publication has 46 references indexed in Scilit:
- Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationThe Lancet Respiratory Medicine, 2025
- The Role of Genetic Testing in Pulmonary FibrosisChest, 2022
- Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severityEBioMedicine, 2021
- Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation studyThe Lancet Respiratory Medicine, 2021
- Adjustment for index event bias in genome-wide association studies of subsequent eventsNature Communications, 2019
- Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyThe Lancet Respiratory Medicine, 2018
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11The Lancet Respiratory Medicine, 2014
- Muc5b is required for airway defenceNature, 2013
- Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary FibrosisJAMA, 2013
- A Better Coefficient of Determination for Genetic Profile AnalysisGenetic Epidemiology, 2012